Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3iu57q0
via IFTTT